Cargando…

Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry

HIV elite controllers maintain a population of CD4 + T cells endowed with high avidity for Gag antigens and potent effector functions. How these HIV-specific cells avoid infection and depletion upon encounter with the virus remains incompletely understood. Ex vivo characterization of single Gag-spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Claireaux, Mathieu, Robinot, Rémy, Kervevan, Jérôme, Patgaonkar, Mandar, Staropoli, Isabelle, Brelot, Anne, Nouël, Alexandre, Gellenoncourt, Stacy, Tang, Xian, Héry, Mélanie, Volant, Stevenn, Perthame, Emeline, Avettand-Fenoël, Véronique, Buchrieser, Julian, Cokelaer, Thomas, Bouchier, Christiane, Ma, Laurence, Boufassa, Faroudy, Hendou, Samia, Libri, Valentina, Hasan, Milena, Zucman, David, de Truchis, Pierre, Schwartz, Olivier, Lambotte, Olivier, Chakrabarti, Lisa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792008/
https://www.ncbi.nlm.nih.gov/pubmed/35082297
http://dx.doi.org/10.1038/s41467-022-28130-0
_version_ 1784640313221971968
author Claireaux, Mathieu
Robinot, Rémy
Kervevan, Jérôme
Patgaonkar, Mandar
Staropoli, Isabelle
Brelot, Anne
Nouël, Alexandre
Gellenoncourt, Stacy
Tang, Xian
Héry, Mélanie
Volant, Stevenn
Perthame, Emeline
Avettand-Fenoël, Véronique
Buchrieser, Julian
Cokelaer, Thomas
Bouchier, Christiane
Ma, Laurence
Boufassa, Faroudy
Hendou, Samia
Libri, Valentina
Hasan, Milena
Zucman, David
de Truchis, Pierre
Schwartz, Olivier
Lambotte, Olivier
Chakrabarti, Lisa A.
author_facet Claireaux, Mathieu
Robinot, Rémy
Kervevan, Jérôme
Patgaonkar, Mandar
Staropoli, Isabelle
Brelot, Anne
Nouël, Alexandre
Gellenoncourt, Stacy
Tang, Xian
Héry, Mélanie
Volant, Stevenn
Perthame, Emeline
Avettand-Fenoël, Véronique
Buchrieser, Julian
Cokelaer, Thomas
Bouchier, Christiane
Ma, Laurence
Boufassa, Faroudy
Hendou, Samia
Libri, Valentina
Hasan, Milena
Zucman, David
de Truchis, Pierre
Schwartz, Olivier
Lambotte, Olivier
Chakrabarti, Lisa A.
author_sort Claireaux, Mathieu
collection PubMed
description HIV elite controllers maintain a population of CD4 + T cells endowed with high avidity for Gag antigens and potent effector functions. How these HIV-specific cells avoid infection and depletion upon encounter with the virus remains incompletely understood. Ex vivo characterization of single Gag-specific CD4 + T cells reveals an advanced Th1 differentiation pattern in controllers, except for the CCR5 marker, which is downregulated compared to specific cells of treated patients. Accordingly, controller specific CD4 + T cells show decreased susceptibility to CCR5-dependent HIV entry. Two controllers carried biallelic mutations impairing CCR5 surface expression, indicating that in rare cases CCR5 downregulation can have a direct genetic cause. Increased expression of β-chemokine ligands upon high-avidity antigen/TCR interactions contributes to autocrine CCR5 downregulation in controllers without CCR5 mutations. These findings suggest that genetic and functional regulation of the primary HIV coreceptor CCR5 play a key role in promoting natural HIV control.
format Online
Article
Text
id pubmed-8792008
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87920082022-02-07 Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry Claireaux, Mathieu Robinot, Rémy Kervevan, Jérôme Patgaonkar, Mandar Staropoli, Isabelle Brelot, Anne Nouël, Alexandre Gellenoncourt, Stacy Tang, Xian Héry, Mélanie Volant, Stevenn Perthame, Emeline Avettand-Fenoël, Véronique Buchrieser, Julian Cokelaer, Thomas Bouchier, Christiane Ma, Laurence Boufassa, Faroudy Hendou, Samia Libri, Valentina Hasan, Milena Zucman, David de Truchis, Pierre Schwartz, Olivier Lambotte, Olivier Chakrabarti, Lisa A. Nat Commun Article HIV elite controllers maintain a population of CD4 + T cells endowed with high avidity for Gag antigens and potent effector functions. How these HIV-specific cells avoid infection and depletion upon encounter with the virus remains incompletely understood. Ex vivo characterization of single Gag-specific CD4 + T cells reveals an advanced Th1 differentiation pattern in controllers, except for the CCR5 marker, which is downregulated compared to specific cells of treated patients. Accordingly, controller specific CD4 + T cells show decreased susceptibility to CCR5-dependent HIV entry. Two controllers carried biallelic mutations impairing CCR5 surface expression, indicating that in rare cases CCR5 downregulation can have a direct genetic cause. Increased expression of β-chemokine ligands upon high-avidity antigen/TCR interactions contributes to autocrine CCR5 downregulation in controllers without CCR5 mutations. These findings suggest that genetic and functional regulation of the primary HIV coreceptor CCR5 play a key role in promoting natural HIV control. Nature Publishing Group UK 2022-01-26 /pmc/articles/PMC8792008/ /pubmed/35082297 http://dx.doi.org/10.1038/s41467-022-28130-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Claireaux, Mathieu
Robinot, Rémy
Kervevan, Jérôme
Patgaonkar, Mandar
Staropoli, Isabelle
Brelot, Anne
Nouël, Alexandre
Gellenoncourt, Stacy
Tang, Xian
Héry, Mélanie
Volant, Stevenn
Perthame, Emeline
Avettand-Fenoël, Véronique
Buchrieser, Julian
Cokelaer, Thomas
Bouchier, Christiane
Ma, Laurence
Boufassa, Faroudy
Hendou, Samia
Libri, Valentina
Hasan, Milena
Zucman, David
de Truchis, Pierre
Schwartz, Olivier
Lambotte, Olivier
Chakrabarti, Lisa A.
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry
title Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry
title_full Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry
title_fullStr Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry
title_full_unstemmed Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry
title_short Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry
title_sort low ccr5 expression protects hiv-specific cd4+ t cells of elite controllers from viral entry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792008/
https://www.ncbi.nlm.nih.gov/pubmed/35082297
http://dx.doi.org/10.1038/s41467-022-28130-0
work_keys_str_mv AT claireauxmathieu lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT robinotremy lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT kervevanjerome lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT patgaonkarmandar lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT staropoliisabelle lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT brelotanne lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT nouelalexandre lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT gellenoncourtstacy lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT tangxian lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT herymelanie lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT volantstevenn lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT perthameemeline lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT avettandfenoelveronique lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT buchrieserjulian lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT cokelaerthomas lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT bouchierchristiane lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT malaurence lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT boufassafaroudy lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT hendousamia lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT librivalentina lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT hasanmilena lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT zucmandavid lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT detruchispierre lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT schwartzolivier lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT lambotteolivier lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry
AT chakrabartilisaa lowccr5expressionprotectshivspecificcd4tcellsofelitecontrollersfromviralentry